View of Evaluating Total Lymphocyte Count as a Surrogate Marker for Immunological Monitoring in HIV Patients Receiving Antiretroviral Therapy: Evidence from a Libyan Cohort

Return to Article Details Evaluating Total Lymphocyte Count as a Surrogate Marker for Immunological Monitoring in HIV Patients Receiving Antiretroviral Therapy: Evidence from a Libyan Cohort Download Download PDF